Advancing Research on Mechanisms and Management of Pain for Diseases and Conditions within NIDDK Mission Areas (R01 Clinical Trial Optional) | RFA DK 22 005

Opportunity Information: Apply for RFA DK 22 005

The National Institutes of Health, through the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), released this discretionary grant opportunity to push pain research forward for diseases and conditions that fall within NIDDK mission areas. The central idea is that pain places a major burden on patients quality of life across many NIDDK-relevant conditions, yet the field still lacks a strong, detailed understanding of the biological mechanisms and clinical drivers of that pain. At the same time, day-to-day pain care often relies on imperfect tools for measuring and predicting pain, and on management strategies that can be limited in effectiveness or carry serious risks, including reliance on opioids. This announcement is meant to spur research that closes those gaps by improving both the science of pain and the practical options clinicians have for treating it.

The funding mechanism is an R01 research project grant, and clinical trials are optional, meaning applicants can propose basic, translational, clinical, or mixed programs of work depending on the specific question and approach. The call is broadly investigator-initiated, encouraging creative, hypothesis-driven projects rather than restricting applicants to a narrow set of pre-defined experiments. Proposed studies are expected to generate meaningful new knowledge about the pathophysiology of pain, clarify clinical features and contributors that shape how pain presents and persists, and ultimately support development of improved pain assessment and management approaches tailored to NIDDK-relevant disorders. In practice, that can include work aimed at identifying mechanisms that initiate or maintain pain, discovering or validating biomarkers or other measurable indicators of pain risk or severity, improving phenotyping and measurement methods, and designing or testing interventions that can reduce pain or improve function while minimizing harms associated with current treatments.

A major emphasis is the need for better strategies to measure, predict, and target pain. This reflects an ongoing challenge in medicine: pain is complex, varies widely across individuals, and can be influenced by interacting biological, neurological, metabolic, inflammatory, and psychosocial factors. By encouraging projects that range from basic mechanism studies to translational and clinical research, the opportunity is positioned to support a pipeline from discovery to practical application, including efforts that could lead to new non-opioid approaches, better selection of therapies for specific patient subgroups, or improved clinical decision-making around pain management.

Eligibility is broad and includes many organization types commonly able to apply for NIH grants. Eligible applicants listed include state, county, city or township governments; special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized Native American tribal governments; tribal organizations that are not federally recognized tribal governments; public housing authorities/Indian housing authorities; nonprofits with or without 501(c)(3) status (excluding institutions of higher education in those categories); for-profit organizations other than small businesses; and small businesses. The announcement also explicitly highlights additional eligible applicant categories such as Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISIs), Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), eligible federal agencies, faith-based or community-based organizations, regional organizations, U.S. territories or possessions, and non-U.S. entities (foreign organizations). This breadth signals an intent to attract a wide range of perspectives, patient populations, and research environments, including those that may be well positioned to study pain in underserved or underrepresented communities.

Key administrative details from the source listing include the Funding Opportunity Title "Advancing Research on Mechanisms and Management of Pain for Diseases and Conditions within NIDDK Mission Areas (R01 Clinical Trial Optional)" and the Funding Opportunity Number RFA-DK-22-005. The agency is the National Institutes of Health, the activity categories are listed under food and nutrition and health, and the CFDA number provided is 93.847. The original closing date shown is 2022-03-18, and the creation date is 2022-01-21. The award ceiling and expected number of awards are not specified in the provided source text, which usually means applicants would need to consult the full announcement for budget expectations, project period norms, and any institute-specific guidance.

Taken together, this opportunity is best read as a targeted push to deepen scientific understanding of pain as it relates to NIDDK mission diseases and to translate that understanding into better, safer, and more precise ways to evaluate and manage pain in real-world care. The expected payoff is not only new mechanistic insight, but also practical advances that help clinicians and patients move beyond one-size-fits-all pain treatment and toward approaches that are more predictive, personalized, and effective.

• The National Institutes of Health in the food and nutrition, health sector is offering a public funding opportunity titled "Advancing Research on Mechanisms and Management of Pain for Diseases and Conditions within NIDDK Mission Areas (R01 Clinical Trial Optional)" and is now available to receive applicants.
• Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.847.
• This funding opportunity was created on 2022-01-21.
• Applicants must submit their applications by 2022-03-18. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
• Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.

Apply for RFA DK 22 005

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal: